NCT01839721View on ClinicalTrials.gov

Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation

PHASE3CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

November 30, 2010

Study Completion Date

December 31, 2010

Conditions
CancerDiarrheaAbdominal PainQuality of Life
Interventions
DRUG

Bifilact®

placebo, standard dose 1.3 billion twice a day, high dose 10 billion three time a day

OTHER

placebo

Trial Locations (1)

G1R 2J6

CHU de Québec, radio-oncology departement, Québec

All Listed Sponsors
lead

CHU de Quebec-Universite Laval

OTHER

NCT01839721 - Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation | Biotech Hunter | Biotech Hunter